Cover Image

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Saved in:

Bibliographic Details
Main Authors:	Giuseppe Terrazzano (Author), Valentina Rubino (Author), Anna Teresa Palatucci (Author), Angela Giovazzino (Author), Flavia Carriero (Author), Giuseppina Ruggiero (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
by: Giuseppe Ercolano, et al.
Published: (2019)

Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
by: Valentina Rubino, et al.
Published: (2021)

Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
by: Valentina Rubino, et al.
Published: (2023)

mTOR in Human Diseases
by: Dormond, Olivier
Published: (2019)

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
by: Xiangjin Zheng, et al.
Published: (2021)

mTOR Signaling in Metabolism and Cancer
Published: (2020)

Roles of mTOR in Diabetic Kidney Disease
by: Mako Yasuda-Yamahara, et al.
Published: (2021)

The role of mTOR in age-related diseases
by: Zofia Chrienova, et al.
Published: (2021)

mTOR Inhibition and Tuberous Sclerosis Prevention
by: J Gordon Millichap
Published: (2013)

Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction
by: Yuanyuan Zheng, et al.
Published: (2023)

Targeting PI3K/mTOR signaling in cancer
by: Alexandre Arcaro
Published: (2014)

Whey Protein e a sinalização de mTOR
by: Marcos Roberto Campos de Macêdo
Published: (2016)

Zastosowanie inhibitorów mTOR w wybranych schorzeniach dermatologicznych
by: Karolina Osiecka, et al.
Published: (2011)

Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
by: Bruna A. C. Rattis, et al.
Published: (2022)

The effect of eight weeks of high-intensity interval training on p-mTOR, T-mTOR and fibrosis of cardiac tissue and insulin resistance in diabetic male Wistar rats
by: Saeed Dabagh Nikookheslat, et al.
Published: (2023)

Tetrandrine, an Activator of Autophagy, Induces Autophagic Cell Death via PKC-α Inhibition and mTOR-Dependent Mechanisms
by: Vincent Kam Wai Wong, et al.
Published: (2017)

Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats
by: Shuyu Ge, et al.
Published: (2024)

Management of mTOR inhibitors oral mucositis: current state of knowledge
by: Calvo Anne Sophie, et al.
Published: (2019)

Involvement of mTOR signaling in physiopathology and its potential therapeutic interventions
by: Irene Martín-Bocanegra, et al.
Published: (2024)

The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling
by: Ruohan Zhang, et al.
Published: (2022)

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
by: Mathis Wehming, et al.
Published: (2023)

Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer
by: Suhail Ahmad Mir, et al.
Published: (2023)

Role of nutrients and mTOR signaling in the regulation of pancreatic progenitors development
by: Lynda Elghazi, et al.
Published: (2017)

Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition
by: Aimin Yang, et al.
Published: (2015)

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
by: Dániel Sztankovics, et al.
Published: (2024)

The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway
by: Danilo Figueiredo Soave, et al.
Published: (2016)

mTOR signaling cascade in psoriatic disease: Double kinase mtor inhibitor a novel therapeutic target
by: Smriti K Raychaudhuri, et al.
Published: (2014)

Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR
by: Xiaojia Liu, et al.
Published: (2021)

Mediation of Anti-Keloid Effects of mTOR Inhibitors by Autophagy-Independent Machinery
by: Meng Jiang, et al.
Published: (2021)

Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice
by: Claudia Bürger, et al.
Published: (2017)

Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation
by: Weiyi Xia, et al.
Published: (2022)

Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
by: Bu-Gao Zhou, et al.
Published: (2018)

Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
by: Micol Silic-Benussi, et al.
Published: (2023)

Pharmacological mTOR inhibitors in ameliorating Alzheimer's disease: current review and perspectives
by: Pei-Lun Xie, et al.
Published: (2024)

Glutamine Availability Regulates the Development of Aging Mediated by mTOR Signaling and Autophagy
by: Jiao Zhou, et al.
Published: (2022)

Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma
by: Feng YQ, et al.
Published: (2020)

Inactivation of Minar2 in mice hyperactivates mTOR signaling and results in obesity
by: Saran Lotfollahzadeh, et al.
Published: (2023)

mTOR Inhibitors in the complex treatment of high-risk vascular malformations in children
by: I.M. Benzar, et al.
Published: (2020)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
by: Thomas Jouve, et al.
Published: (2016)

Inflammatory-miR-301a circuitry drives mTOR and Stat3-dependent PSC activation in chronic pancreatitis and PanIN
by: Fugui Li, et al.
Published: (2022)